Current State of Alzheimer's Disease Research and Therapeutics

Content: 
Front Matter
Page iii

Copyright
Page iv

Contributors
Pages xi-xiii

Hsp90 Modulation for the Treatment of Alzheimer’s Disease
Pages 1-25
Huiping Zhao, Mary L. Michaelis, Brian S.J. Blagg

Using Pittsburgh Compound B for In Vivo PET Imaging of Fibrillar Amyloid-Beta
Pages 27-81
Ann D. Cohen, Gil D. Rabinovici, Chester A. Mathis, William J. Jagust, William E. Klunk, Milos D. Ikonomovic

Mitochondrial Abnormalities in Alzheimer’s Disease: Possible Targets for Therapeutic Intervention
Pages 83-126
Diana F. Silva, J. Eva Selfridge, Jianghua Lu, Lezi E, Sandra M. Cardoso, Russell H. Swerdlow

γ-Secretase as a Target for Alzheimer’s Disease
Pages 127-153
Michael S. Wolfe

Altering Mitochondrial Dysfunction as an Approach to Treating Alzheimer’s Disease
Pages 155-176
Jerry R. Colca, Douglas L. Feinstein

scyllo-Inositol, Preclinical, and Clinical Data for Alzheimer’s Disease
Pages 177-212
Keran Ma, Lynsie A.M. Thomason, JoAnne McLaurin

Beyond Amyloid: The Future of Therapeutics for Alzheimer\'s Disease
Pages 213-271
Rachel F. Lane, Diana W. Shineman, John W. Steele, Linda (Bobbi) H. Lee, Howard M. Fillit

Activation of Protein Kinase C Isozymes for the Treatment of Dementias
Pages 273-302
Miao-Kun Sun, Daniel L. Alkon

Striatal-Enriched Protein Tyrosine Phosphatase in Alzheimer’s Disease
Pages 303-325
Jian Xu, Pradeep Kurup, Angus C. Nairn, Paul J. Lombroso

Estrogen Regulation of Mitochondrial Bioenergetics: Implications for Prevention of Alzheimer’s Disease
Pages 327-371
Jia Yao, Roberta Diaz Brinton

Index
Pages 373-382

Recent Volumes in the Serial
Page 383